Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Heal. 2017;5:e1221–34.
Bangal SV, Somasundaram VK, Misra NS. Blindness prevention through screening for diabetic retinopathy and glaucoma in rural population-a novel approach. Int J Biomed Res. 2012;3:46–51.
Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6:69–80.
Stokes A, Collins JM, Grant BF, Scamuffa RF, Hsiao CW, Johnston SS, et al. Obesity progression between young adulthood and midlife and incident diabetes: a retrospective cohort study of U.S. Adults. Diabetes Care. 2018;41:1025–31.
Article PubMed PubMed Central Google Scholar
Maric-Bilkan C. Obesity and diabetic kidney disease. Med Clin North Am. 2013;97:59–74.
Van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn Study. Diabetes Care. 2002;25:1320–5.
Henricsson M, Nyström L, Blohmé G, Östman J, Kullberg C, Svensson M, et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care. 2003;26:349–54.
Lee ET, Keen H, Bennett PH, Fuller JH, Lu M. The appearance of retinopathy and progression to proliferative retinopathy: the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44:S22–30.
Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care. 2001;24:1275–9.
Article CAS PubMed Google Scholar
Man REK, Sabanayagam C, Chiang PPC, Li LJ, Noonan JE, Wang JJ, et al. Differential association of generalized and abdominal obesity with diabetic retinopathy in Asian patients with type 2 diabetes. JAMA Ophthalmol. 2016;134:251–7.
Tryggestad JB, Kelsey MM, Drews KL, Chernausek SD, Escaname EN, Isganaitis E, et al. Development and progression of diabetic retinopathy in adolescents and young adults with type 2 diabetes: results From the TODAY study. Diabetes Care. 2021;45:1049–55.
Dowse GK, Humphrey ARG, Collins VR, Plehwe W, Gareeboo H, Fareed D, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol. 1998;147:448–57.
Article CAS PubMed Google Scholar
Chan JCY, Chee ML, Tan NYQ, Cheng CY, Wong TY, Sabanayagam C. Differential effect of body mass index on the incidence of diabetes and diabetic retinopathy in two Asian populations. Nutr Diabetes. 2018;8:16.
Lim LS, Shyong Tai E, Mitchell P, Wang JJ, Tay WT, Lamoureux E, et al. C-reactive protein, body mass index, and diabetic retinopathy. Invest Ophthalmol Vis Sci. 2010;51:4458–63.
Klein R, Klein BE, Moss SE. Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med. 1997;157:650–6.
Article CAS PubMed Google Scholar
Van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol. 2003;121:245–51.
Wong TY, Klein R, Islam FMA, Cotch MF, Folsom AR, Klein BEK, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141:446–55.
Article PubMed PubMed Central Google Scholar
Jensen ET, Rigdon J, Rezaei KA, Saaddine J, Lundeen EA, Dabelea D, et al. Prevalence, progression, and modifiable risk factors for diabetic retinopathy in youth and young adults with youth-onset type 1 and type 2 diabetes: the SEARCH for diabetes in youth study. Diabetes Care. 2023;46:1252–60.
Article PubMed PubMed Central Google Scholar
Zhong P, Tan S, Zhu Z, Zhu Z, Liang Y, Huang W, et al. Normal‐weight central obesity and risk of cardiovascular and microvascular events in adults with prediabetes or diabetes: Chinese and British cohorts. Diabetes Metab Res Rev. 2023;39:e3707.
Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol 2015;402:113–9.
Article CAS PubMed Google Scholar
Després J-P. Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012;126:1301–13.
Snijder MB, Visser M, Dekker JM, Goodpaster BH, Harris TB, Kritchevsky SB, et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia. 2005;48:301–8.
Article CAS PubMed Google Scholar
Wander PL, Boyko EJ, Leonetti DL, McNeely MJ, Kahn SE, Fujimoto WY. Change in visceral adiposity independently predicts a greater risk of developing type 2 diabetes over 10 years in Japanese Americans. Diabetes Care. 2013;36:289–93.
Article PubMed PubMed Central Google Scholar
Okosun IS, Seale JP, Lyn R. Commingling effect of gynoid and android fat patterns on cardiometabolic dysregulation in normal weight American adults. Nutr Diabetes 2015;5:e155–e155.
Article CAS PubMed PubMed Central Google Scholar
Abraham TM, Pedley A, Massaro JM, Hoffmann U, Fox CS. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation. 2015;132:1639.
Article CAS PubMed PubMed Central Google Scholar
Brahimaj A, Rivadeneira F, Muka T, Sijbrands EJG, Franco OH, Dehghan A, et al. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study. Diabetologia. 2019;62:1581–90.
Article CAS PubMed PubMed Central Google Scholar
Aucouturier J, Meyer M, Thivel D, Taillardat M, Duché P. Effect of android to gynoid fat ratio on insulin resistance in obese youth. Arch Pediatr Adolesc Med. 2009;163:826–31.
Ciardullo S, Oltolini A, Cannistraci R, Muraca E, Perseghin G. Sex-related association of nonalcoholic fatty liver disease and liver fibrosis with body fat distribution in the general US population. Am J Clin Nutr. 2022;115:1528–34.
Bouchi R, Nakano Y, Ohara N, Takeuchi T, Murakami M, Asakawa M, et al. Clinical relevance of dual-energy X-ray absorptiometry (DXA) as a simultaneous evaluation of fatty liver disease and atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2016;15:64.
Article PubMed PubMed Central Google Scholar
Fukuda T, Bouchi R, Takeuchi T, Tsujimoto K, Minami I, Yoshimoto T, et al. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study. Cardiovasc Diabetol. 2018;17:1–12.
Lu Z, Tilly MJ, Aribas E, Bos D, Geurts S, Stricker BH, et al. Imaging-based body fat depots and new-onset atrial fibrillation in general population: a prospective cohort study. BMC Med. 2022;20:317.https://pubmed.ncbi.nlm.nih.gov/36117169/
Wang L, Li X, Wang Z, Bancks MP, Carnethon MR, Greenland P, et al. Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018. JAMA. 2021;326:704–16.
Wang S, Wang Y, Wan X, Guo J, Zhang Y, Tian M, et al. Cobalamin intake and related biomarkers: examining associations with mortality risk among adults with type 2 diabetes in NHANES. Diabetes Care. 2022;45:276–84.
Article CAS PubMed Google Scholar
Jiang W, Zhang J, Yang R, Sun X, Wu H, Zhang J, et al. Association of urinary nitrate with diabetes complication and disease-specific mortality among adults with hyperglycemia. J Clin Endocrinol Metab. 2023;108:1318.
Sun X-J, Zhang G-H, Guo C-M, Zhou Z-Y, Niu Y-L, Wang L, et al. Associations between psycho-behavioral risk factors and diabetic retinopathy: NHANES (2005-2018). Front Public Health. 2022;10:966714.
留言 (0)